Motley Fool Premium
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (TSX: BHC)
    3. /

TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A High-Risk/High-Reward Stock for Patient Rebound Hunters

    | Joey Frenette

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is picking up negative momentum. Should you buy the dip or follow the herd?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.’s Q3 Results Boosted by Non-Operating Items

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) released its Q3 results today. Results failed to show any sales growth or improved profitability from…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Has Thrown in the Towel: Should You?

    | Ryan Goldsman

    After giving up another revenue-generating asset, investors need to cut ties with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Shopify Inc. Reports Earnings, Shares Fall, But it’s Only the Beginning

    | Ryan Goldsman

    After failing to meet expectations, the fall of Shopify Inc. (TSX:SHOP)(NYSE:SHOP) may only be starting.

    Read more »

    win
    Dividend Stocks

    4 Oversold Stocks That Could Take Off!

    | David Jagielski

    Barrick Gold Corp. (TSX:ABX)(NYSE:ABX) and these three other stocks have seen big drops in price recently, and it could be a…

    Read more »

    Tech Stocks

    Shopify Inc. Takes Another Left Hook to the Chin

    | Joey Frenette

    Shopify Inc. (TSX:SHOP)(NYSE:SHOP) is back in the red following retorts by management. Should investors throw in the towel before another…

    Read more »

    Dividend Stocks

    Where to Invest When Looking Forward to 2018

    | Ryan Goldsman

    Investors wanting to be best positioned going into 2018 will need to carefully consider shares of First National Financial Corp.…

    Read more »

    The Motley Fool
    Investing

    3 Tips That Will Help You Avoid Value Traps

    | Jason Phillips

    Value investors are often drawn to companies like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) for good reason. But be careful to…

    Read more »

    Investing

    What to Do When Short Sellers Attack

    | Joey Frenette

    Shopify Inc. (TSX:SHOP)(NYSE:SHOP) has been hit hard by short seller Andrew Left. Here's what investors should do if their stock…

    Read more »

    Bank Stocks

    Why it Might Be Wise to Steer Clear of Bank Stocks and Other Lending Companies

    | David Jagielski

    Why shareholders of First National Financial Corp. (TSX:FN) and other financial institutions might want to consider selling their shares.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Different Company, but Better Investment?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a very different company from the one that crashed two years ago, but is…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is Down 15%: Is it a Buy?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a high-risk play, but if it can take the necessary steps, it might just…

    Read more »